FRAX Score: Comprehensive Overview
FRAX is a WHO-developed computer algorithm that calculates the 10-year probability of hip fracture and major osteoporotic fracture (hip, clinical spine, humerus, or wrist) using easily obtainable clinical risk factors, with or without bone mineral density, to guide treatment decisions in osteoporosis management. 1
What FRAX Calculates
FRAX provides two specific outputs:
- 10-year probability of hip fracture
- 10-year probability of major osteoporotic fracture (MOF: hip, clinical spine, humerus, or wrist)
The algorithm integrates both fracture risk and mortality risk, making it particularly valuable as it represents lifetime probability at older ages where life expectancy may be less than 10 years 1.
Input Variables for FRAX Calculation
FRAX requires the following 11 clinical risk factors 2, 3:
Demographic factors:
- Age (40-90 years)
- Sex
- Weight and height (to calculate BMI)
- Country of residence
- Ethnicity (in US models: White, Black, Hispanic, Asian)
Clinical risk factors (all dichotomous yes/no):
- Prior fragility fracture (including radiographic vertebral fracture)
- Parental history of hip fracture
- Current tobacco smoking
- Glucocorticoid use (≥5 mg prednisone daily for ≥3 months, current or past)
- Rheumatoid arthritis
- Secondary osteoporosis (type 1 diabetes, osteogenesis imperfecta, untreated hyperthyroidism, hypogonadism, premature menopause, chronic malnutrition/malabsorption, chronic liver disease)
- Alcohol consumption (≥2 units daily)
Optional enhancement:
- Femoral neck BMD (significantly improves prediction accuracy) 1
How FRAX Guides Management
Treatment Thresholds
Standard intervention thresholds (endorsed by National Osteoporosis Foundation) 3, 4:
- 10-year hip fracture risk ≥3% → Consider pharmacologic treatment
- 10-year major osteoporotic fracture risk ≥20% → Consider pharmacologic treatment
Risk Stratification in Glucocorticoid-Induced Osteoporosis
For patients on glucocorticoids, FRAX requires adjustment 5:
- Multiply FRAX MOF risk by 1.15 if glucocorticoid dose >7.5 mg/day
- Multiply FRAX hip fracture risk by 1.2 if glucocorticoid dose >7.5 mg/day
Risk categories for adults ≥40 years on glucocorticoids 5:
High fracture risk:
- FRAX (GC-adjusted) 10-year MOF risk ≥20%
- FRAX (GC-adjusted) 10-year hip fracture risk ≥3%
- Prior osteoporotic fracture(s)
- Hip or spine T-score ≤-2.5
Moderate fracture risk:
- FRAX (GC-adjusted) 10-year MOF risk 10-19%
- FRAX (GC-adjusted) 10-year hip fracture risk >1% and <3%
Low fracture risk:
- FRAX (GC-adjusted) 10-year MOF risk <10%
- FRAX (GC-adjusted) 10-year hip fracture risk ≤1%
Clinical Application Algorithm
Step 1: Identify candidates for FRAX assessment
- Postmenopausal women and men ≥50 years
- Patients with T-scores between -1.0 and -2.5 (osteopenia) 3, 4
- Patients on long-term glucocorticoids
- Those with clinical risk factors but no prior fracture
Step 2: Calculate FRAX score
- Use country-specific calculator (https://www.shef.ac.uk/FRAX/tool.jsp)
- Include femoral neck BMD when available (improves accuracy)
- Apply glucocorticoid adjustment if dose >7.5 mg/day
Step 3: Interpret results and act
- Hip fracture risk ≥3% OR MOF risk ≥20% → Initiate pharmacologic therapy
- Prior fragility fracture in older adult → Treat regardless of FRAX score 1
- T-score ≤-2.5 → Treat regardless of FRAX score 3
Key Advantages of FRAX
- Captures risk beyond BMD alone: Most fractures occur in patients with osteopenia (T-score -1.0 to -2.5), not osteoporosis 1
- Identifies more at-risk patients: T-score criteria alone miss approximately 75% of men who will fracture 4
- Country-specific calibration: Accounts for geographic variations in fracture incidence 1
- Can be used without BMD: Useful in settings where DXA is unavailable 1
- Validated in both sexes: Applicable to postmenopausal women and men aged 40-90 years 1, 3
Important Limitations and Caveats
FRAX underestimates risk in:
- Patients with multiple prior fractures (only counts as yes/no)
- High-dose glucocorticoid users (binary input only)
- Heavy alcohol users (≥3 units/day not captured)
- Patients with frequent falls or frailty
- Type 2 diabetes mellitus
- Recent fractures (higher imminent risk)
Race-specific concerns 6:
- US versions use race-specific fracture incidence data
- May systematically underestimate risk in non-White populations
- Creates potential for treatment disparities among patients with identical clinical profiles
- Unclear which calculator to use for multiracial individuals or recent immigrants
Technical limitations 6:
- Does not incorporate lumbar spine BMD
- Does not include trabecular bone score
- Based on cohort data 30-40 years old
- Mortality estimates not updated since 2004
- Only validated for untreated patients 7
When FRAX Alone Is Insufficient
Automatically treat without FRAX calculation:
- Prior hip or vertebral fracture in older adults 1
- T-score ≤-2.5 at age ≥70 years 8
- Two or more osteoporotic fractures 8
Use clinical judgment to override FRAX when:
- High fall risk present
- Rapid bone loss documented (≥10% at hip/spine over 1 year) 5
- Multiple risk factors not captured by FRAX
- Very high imminent fracture risk (recent fracture, very low BMD)
Monitoring and Reassessment
FRAX should be recalculated when:
- New fractures occur
- BMD changes significantly
- New risk factors develop
- Considering treatment discontinuation
Critical point: FRAX provides absolute fracture probability, which is more clinically meaningful than relative risk and enables equitable treatment decisions across age groups and populations 1.